This pipeline computes the correlation between significantly recurrent gene mutations and selected clinical features.
Testing the association between mutation status of 7 genes and 8 clinical features across 101 patients, one significant finding detected with Q value < 0.25.
-
IL32 mutation correlated to 'Time to Death'.
Clinical Features |
Time to Death |
AGE | GENDER |
KARNOFSKY PERFORMANCE SCORE |
PATHOLOGY T |
PATHOLOGY N |
PATHOLOGICSPREAD(M) |
TUMOR STAGE |
||
nMutated (%) | nWild-Type | logrank test | t-test | Fisher's exact test | t-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
IL32 | 4 (4%) | 97 |
9.44e-15 (4.15e-13) |
0.366 (1.00) |
0.3 (1.00) |
0.776 (1.00) |
0.22 (1.00) |
0.667 (1.00) |
||
MET | 7 (7%) | 94 |
0.695 (1.00) |
0.881 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.799 (1.00) |
||
CDC27 | 4 (4%) | 97 |
0.598 (1.00) |
0.78 (1.00) |
0.595 (1.00) |
0.776 (1.00) |
0.132 (1.00) |
0.345 (1.00) |
||
NF2 | 7 (7%) | 94 |
0.598 (1.00) |
0.3 (1.00) |
1 (1.00) |
0.437 (1.00) |
0.0583 (1.00) |
0.0363 (1.00) |
0.162 (1.00) |
|
SFRS2IP | 5 (5%) | 96 |
0.226 (1.00) |
0.121 (1.00) |
0.661 (1.00) |
0.102 (1.00) |
1 (1.00) |
0.0829 (1.00) |
0.316 (1.00) |
|
LGI4 | 4 (4%) | 97 |
0.19 (1.00) |
0.91 (1.00) |
0.3 (1.00) |
0.776 (1.00) |
0.715 (1.00) |
0.667 (1.00) |
||
BHMT | 3 (3%) | 98 |
0.383 (1.00) |
0.703 (1.00) |
0.549 (1.00) |
1 (1.00) |
0.627 (1.00) |
0.562 (1.00) |
P value = 9.44e-15 (logrank test), Q value = 4.2e-13
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 94 | 14 | 0.0 - 182.7 (13.9) |
IL32 MUTATED | 4 | 1 | 3.6 - 7.9 (4.8) |
IL32 WILD-TYPE | 90 | 13 | 0.0 - 182.7 (14.6) |
-
Mutation data file = KIRP-TP.mutsig.cluster.txt
-
Clinical data file = KIRP-TP.clin.merged.picked.txt
-
Number of patients = 101
-
Number of significantly mutated genes = 7
-
Number of selected clinical features = 8
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.